NCT00326768 - Trial of Telmisartan 80 mg/HCTZ 12.5 mg and Telmisartan 40 mg/HCTZ 12.5 mg in Patients With Hypertension | Biotech Hunter

Enrollment

184

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions

Hypertension

Interventions

DRUG

Telmisartan 40 mg/HCTZ 12.5 mg

DRUG

Telmisartan 40 mg

DRUG

Telmisartan 80 mg/HCTZ 12.5 mg

Trial Locations (3)

Boehringer Ingelheim Investigational Site, Hiroshima-shi, Hiroshima

Boehringer Ingelheim Investigational Site, Sapporo-shi, Hokkaido

Boehringer Ingelheim Investigational Site, Shinjuku-ku, Tokyo